Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Human Insulin Drugs and Delivery Devices Market to reach USD 49.6 billion by 2028.

Global Human Insulin Drugs and Delivery Devices Market Size study, by Drug Type (Basal or Long-acting Insulins, Bolus or Fast-acting Insulins, Traditional Human Insulins, Combination Insulins, and Biosimilar Insulins), by Device Type (Insulin Pens, Insulin Pumps, Insulin Syringes, and Jet Injectors) and Regional Forecasts 2022-2028

Product Code: HLSMDE-14476981
Publish Date: 15-09-2022
Page: 200

Global Human Insulin Drugs and Delivery Devices Market is valued at approximately USD 40.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2022-2028. Protein hormone insulin helps people whose systems are unable to manufacture enough insulin control high blood sugar levels. By enhancing glucose uptake in fatty tissues and muscles, insulin reduces the blood glucose level. This can be infused in buttocks, belly, backs of the arms, or legs. Additionally, insulin not only aids in the management of diabetes but also in the treatment of its immediate consequences, including diabetic ketoacidosis and hyperosmolar hyperglycemia. The market growth is driven by key factors such as growth in the number of diabetic patients and rising market demand for HI Analogs. According to a Commonwealth Fund study, Americans with diabetes who lack insurance are more likely to use older, less expensive (and less effective) insulin medications than those who have Medicaid or private insurance. 60% to 80% of people without insurance pay the entire list price for insulin, compared to 9% of privately insured patients and 3% of Medicaid recipients. Moreover, expected patent expiry of key HI Drugs propels the market opportunities across the globe. However, stringent regulatory requirements for product approval impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Human Insulin Drugs and Delivery Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to high cases and increasing amount of diabetic patients. However, Asia Pacific is expected to be the fastest growing region due to changing lifestyles of people and unhealthy dietary habits.

Major market players included in this report are:
Novo Nordisk A/S
Insulet
Eli Lilly
Exir
Biocon
Becton Dickinson
Medtronic
Ypsomed
Julphar
Sanofi Aventis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:
Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Combination Insulins
Biosimilar Insulins

By Device Type:
Insulin Pens
Insulin Pumps
Insulin Syringes
Jet Injectors

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Human Insulin Drugs and Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics
3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growth in the Number of Diabetic Patients
3.1.1.2. Rising Market Demand for HI Analogs
3.1.2. Market Challenges
3.1.2.1. Stringent Regulatory Requirements for Product Approval
3.1.3. Market Opportunities
3.1.3.1. Expected Patent Expiry of Key HI Drugs
3.1.3.2. Emerging Markets
Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type
6.1. Market Snapshot
6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance – Potential Analysis
6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
6.4.1. Basal or Long-acting Insulins
6.4.2. Bolus or Fast-acting Insulins
6.4.3. Traditional Human Insulins
6.4.4. Combination Insulins
6.4.5. Biosimilar Insulins
Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type
7.1. Market Snapshot
7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance – Potential Analysis
7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
7.4.1. Insulin Pens
7.4.2. Insulin Pumps
7.4.3. Insulin Syringes
7.4.4. Jet Injectors
Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis
8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
8.2. North America Human Insulin Drugs and Delivery Devices Market
8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
8.3.3. France Human Insulin Drugs and Delivery Devices Market
8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
8.4.1. China Human Insulin Drugs and Delivery Devices Market
8.4.2. India Human Insulin Drugs and Delivery Devices Market
8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Sanofi Aventis
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Novo Nordisk A/S
9.2.3. Insulet
9.2.4. Eli Lilly
9.2.5. Exir
9.2.6. Biocon
9.2.7. Becton Dickinson
9.2.8. Medtronic
9.2.9. Ypsomed
9.2.10. Julphar
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now